Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.39 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21143357 | 0.90 | EPHX2 (0.39) | NAAACYP2C19EPHX1HTTGAA | |
| SCHEMBL6058407 | 0.89 | NAAA (0.48) | NAAACYP2C19EPHX1HTTCYP19A1 | |
| SCHEMBL240891 | 0.89 | NAAA (0.53) | NAAACYP2C19EPHX1HTTCYP19A1 | |
| SCHEMBL1645649 | 0.87 | NAAA (0.38) | NAAACYP2C19EPHX1HTTGAA | |
| SCHEMBL242936 | 0.87 | CYP2C19 (0.57) | NAAACYP2C19EPHX1HTTCYP19A1 | |
| SCHEMBL17920350 | 0.87 | CYP2C19 (0.57) | NAAACYP2C19EPHX1HTTCYP19A1 | |
| SCHEMBL7740543 | 0.85 | GAA (0.50) | NAAACYP2C19EPHX1HTTGAA | |
| SCHEMBL5793189 | 0.85 | TDP1 (0.38) | NAAACYP2C19EPHX1HTTGAA | |
| SCHEMBL11293843 | 0.85 | GAA (0.50) | NAAACYP2C19EPHX1HTTGAA | |
| SCHEMBL5351116 | 0.85 | NAAA (0.37) | NAAACYP2C19EPHX1HTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113249014-B | Deep sea anticorrosive paint and preparation method thereof | 启东海大聚龙新材料科技有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-113372791-A | Marine heavy-duty anticorrosive paint and preparation method thereof | 启东海大聚龙新材料科技有限公司 | 2021-09-10 | — | — | CN | claimed |
| CN-113249014-A | Deep sea anticorrosive paint and preparation method thereof | 启东海大聚龙新材料科技有限公司 | 2021-08-13 | — | — | CN | claimed |
| CN-112574205-A | Preparation method of tofacitini water hydrolysis impurities | 鲁南制药集团股份有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-115819222-A | Preparation method of valproic acid | 湖南省湘中制药有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-114957065-A | Malonic acid dithioester compound, preparation method and application thereof | 沈阳化工大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-111233880-B | Preparation method of hypochlorite fluorescent probe | 江苏大学 | 2022-08-23 | — | — | CN | disclosed |
| CN-113249014-B | Deep sea anticorrosive paint and preparation method thereof | 启东海大聚龙新材料科技有限公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-113845424-A | Right camphol ester compound and pharmaceutical application thereof | 南京医科大学 | 2021-12-28 | — | — | CN | disclosed |
| CN-113372791-A | Marine heavy-duty anticorrosive paint and preparation method thereof | 启东海大聚龙新材料科技有限公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-113249014-A | Deep sea anticorrosive paint and preparation method thereof | 启东海大聚龙新材料科技有限公司 | 2021-08-13 | — | — | CN | disclosed |
| CN-111146496-B | Polymer electrolyte and lithium ion battery containing same | 珠海冠宇电池股份有限公司 | 2021-07-13 | — | — | CN | disclosed |
| EP-1924594-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | Intermune, Inc. (US) | 2008-05-28 | — | — | EP | disclosed |
| US-7300953-B2 | Process for preparing nitrile compound, carboxylic acid compound or carboxylic acid ester compound | UBE INDUSTRIES, LTD (JP) | 2007-11-27 | — | — | US | disclosed |
| US-20070054842-A1 | Novel macrocyclic inhibitors of hepatitis C virus replication | ARRAY BIOPHARMA, INC. | 2007-03-08 | — | — | US | disclosed |
| WO-2007015824-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20060287541-A1 | Subjecting a 4-substituted tetrahydropyran-4-carboxylic acid compound to to decarboxylation in the presence of a metal catalyst for producing 4-substituted tetrahydropyran | UBE INDUSTRIES, LTD. (JP) | 2006-12-21 | — | — | US | disclosed |
| EP-1671937-A1 | METHOD FOR PRODUCING NITRILE COMPOUND, CARBOXYLIC ACID COMPOUND OR CARBOXYLATE COMPOUND | Ube Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | disclosed |
| CN-1040105-C | Aminoketone derivatives and use thereof | MITZUI TOATSU CHEMICALS INC (JP) | 1998-10-07 | — | — | CN | disclosed |
| CN-1049660-A | Aminoketone derivative and application thereof | MITZUI TOATSU CHEMICALS INC (JP) | 1991-03-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287541-A1 | Subjecting a 4-substituted tetrahydropyran-4-carboxylic acid compound to to decarboxylation in the presence of a metal catalyst for producing 4-substituted tetrahydropyran | CBR1, ALDH18A1, ME1 | NAAA 30/4885CYP2C19 98/4885EPHX1 2673/4885 |
| US-20070054842-A1 | Novel macrocyclic inhibitors of hepatitis C virus replication | EIF2AK2, HAVCR2, HCCS | NAAA 3554/4885CYP2C19 1733/4885EPHX1 2160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.